Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
Moderna(MRNA) stock is priced at $167.34, giving the company a market capitalization of 66.81B. It carries a P/E multiple of -19.29.
During the trading session on 2026-09-21, Moderna(MRNA) shares reached a daily high of $169.18 and a low of $156.02. At a current price of $167.34, the stock is +7.3% higher than the low and still -1.1% under the high.
Trading activity shows a volume of 4.68M, compared to an average daily volume of 12.48M.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $176.66 and a low of $22.28.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $176.66 and a low of $22.28.
MRNA News
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to 51,778.04, the S&P 500 advancing 1.14% to 7,637.76 and the N...
Moderna Inc. (NASDAQ:MRNA) shares are popping Thursday, extending a month-long rally that began with a Phase 3 cancer vaccine breakthrough. Moderna shares are...
Moderna, Inc‘s (NASDAQ:MRNA) biggest problem is no longer proving that its mRNA technology can work against cancer. Investors got that answer in August. The ha...
Analyst ratings
64%
of 25 ratingsMore MRNA News
Investing Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher Cancer vaccine momentum is doing the work for Moderna...
Moderna (MRNA) moved back into focus after its shares closed at US$146.69, rising 1.89% on a day when major indexes fell, ahead of an earnings report expected t...
Key Points Moderna's recent success in a phase 3 clinical trial for its personalized cancer vaccine was a breakthrough. This product could rival the lifetime...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.